Schedule 13D ownership disclosure

Lineage Cell Therapeutics Inc

Common Shares, no par value · CUSIP: 53566P109

Event date: 2025-01-27

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • BROADWOOD PARTNERS, L.P.Reported CIK 0001278386

    Shares: 57,455,729.00 · Class: 24.3%

  • BROADWOOD CAPITAL, INC.Reported CIK 0001278387

    Shares: 57,455,729.00 · Class: 24.3%

  • NEAL C. BRADSHERReported CIK 0001278388

    Shares: 57,848,357.00 · Class: 24.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-25-000556
Form type
SCHEDULE 13D/A
Filer
BROADWOOD PARTNERS, L.P.
CIK
CIK 1278386
Filed
Jan 28, 2025
Reporting period
Jan 27, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub